Daraxonrasib (Rasonque by Revolution Medicines, Inc.), an inhibitor of the RAS GTPase family has been approved for the treatment of adults with metastatic pancreatic...
The current orthoebolavirus outbreak in Democratic Republic of Congo (DRC) and Uganda is confirmed to be caused by the species Orthoebolavirus bundibugyoense (Bundibugyo virus),...
Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...
Multidrug resistant tuberculosis (MDR TB) affects half a million people each year. Levofloxacin is advised for preventive treatment based on observational data, however evidence...
Ryoncil has been approved for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), a life-threatening condition that may result from blood stem cell transplantation...
A recent study has estimated disease frequency of herpes simplex virus (HSV) infections and genital ulcer disease (GUD). The estimates suggest that about 846...
On October 22, 2024, a surgical team performed the first fully robotic double lung transplant on a 57-year-old woman with chronic obstructive pulmonary disease...
Asciminib (Scemblix) has been approved for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). The accelerated approval...
On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval as a new drug for...